Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) / Gilead, Japan Tobacco 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
11 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) / Gilead, Japan Tobacco
2014-004015-36: Role of a switch to an once-daily regimen of antiretroviral therapy on HIV-DNA levels and immune activation. Effetti del passaggio a un regime HAART in unica somministrazione giornaliera sui livelli di HIV-DNA e dei livelli di attivazione immunitaria.

Ongoing
4
30
Europe
STRIBILD, Film-coated tablet, STRIBILD
AZIENDA OSPEDALIERA SAN PAOLO, Gilead Sciences S.r.l.
Human Immunodeficiency Virus (HIV-1) Infection Infezione da virus dell’immunodeficienza umana (HIV1), HIV virus Infection Infezione da virus HIV, Diseases [C] - Virus Diseases [C02]
 
 
2015-000274-35: clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged virological suppression. ENSAYO CLÍNICO PARA EVALUAR LA SEGURIDAD, TOLERABILIDAD Y EFICACIA DE DOS ESTRATEGIAS DE SIMPLIFICACIÓN BASADAS EN DOLUTEGRAVIR EN PACIENTES INFECTADOS POR VIH CON SUPRESIÓN VIROLÓGICA SOSTENIDA.

Ongoing
4
450
Europe
Lamivudine, Efavirenz, nevirapine, J05AX12, Coated tablet, Capsule, hard, Tablet, Prolonged-release tablet, Tivicay, Stribild, TRUVADA, KIVEXA, ZIAGEN, VIREAD, EMTRIVA, ATRIPLA, EVIPLERA, ISENTRESS, RAYATAZ, PREZISTA, KALETRA, NORVIR, INTELENCE, EDURANT, TRIUMEQ
Fundació Lluita contra la SIDA, Fundació Lluita contra la SIDA
Infection with human immunodeficiency virus (HIV). Infección por el virus de la inmunodeficiencia humana (VIH)., HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
2014-004578-40: SSAT 066 Renal Integrase Study

Not yet recruiting
4
60
Europe
Tivicay 50 mg film - coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets, Film-coated tablet, Tivicay 50 mg film-coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets
St Stephen's AIDS Trust, Merck, Sharp & Dohme Limited
HIV
 
 
2017-002855-27: BonE health in ageING Women: Improvement or prevention of changes in Bone MineralDensity by Switching Antiretroviral Agents. Is there an optimal time to intervene? La salute delle ossa nell¿invecchiamento femminile: miglioramento o prevenzione delle variazioni di densit¿ minerale ossea modificando i farmaci antiretrovirali. Esiste un momento ottimale per intervenire?

Not yet recruiting
4
128
Europe
truvada, stribild, eviplera, genvoya, descovy, Odefsey, J05AR03, eviplera, J05AR18, J05AR17, J05AR19, Film-coated tablet, TRUVADA - 30 COMPRESSE RIVESTITE CON FILM IN FLACONE HDPE DA 200 MG/245 MG, STRIBILD - 150MG/150MG/200MG/245MG/ - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) - 30 COMPRESSE, EVIPLERA - 25MG RILPIVIRINA/200MG EMTRICITABINA/245MG TENOFOVIR DISOPROXIL-COMPRESSA RIVESTITA CON FILM-USO ORALE-FLACONE (HDPE) 30 COMPRESSE, GENVOYA - 150 MG / 150 MG / 200 MG /10 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- FLACONE (HDPE)- 30 COMPRESSE, DESCOVY - 200 MG/10 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- FLACONE (HDPE)- 30 COMPRESSE, ODEFSEY - 200 MG/25 MG/25 MG- COMPRESSA RIVESTITA- USO ORALE- FLACONE (HDPE) 30 COMPRESSE
UNIVERSITY HEALTH NETWORK, Gilead Sciences, Canadian HIV Trials Network
HIV infection and menopause infezione da HIV e menopausa, HIV infection and menopause infezione da HIV e menopausa, Diseases [C] - Virus Diseases [C02]
 
 
2017-004750-42: EFFICACY AND SAFETY OF A SIMPLIFICATION TREATMENT BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS USUAL TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS WITH MULTIDRUG RESISTANCE. Eficacia y seguridad de Dolutegravir más Darunavir/cobicistat como tratamiento de simplificación frente al tratamiento habitual en pacientes infectados por el VIH-1 virológicamente suprimidos y con resistencia a múltiples fármacos.

Ongoing
4
100
Europe
lamivudine, Efavirenz, Nevirapine, Film-coated tablet, Coated tablet, Capsule, hard, Tablet, Rezolsta, Tivicay, Ziagen, EMTRIVA, VIREAD, kivexa, Truvada, Intelence, Edurant, Atripla, Eviplera, Reyataz, Prezista, Kaletra, Norvir, Evotaz, Isentress, Stribild, Triumeq, Genvoya, Celsentri, Descovy
FUNDACIÓ LLUITA CONTRA LA SIDA, ViiV Healthcare
HIV-1 VIH-1, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
2018-004499-36: study to assess the changes in bone health after changing from a TDF based regimen to Bicetegravir-Tenofovir Alafenamide-Emtricitavine based treatment Estudio para evaluar los cambios en la salud ósea tras el paso de un régimen basado en TDF a uno basado en Bictegravir-Tenofovir Alafenamida-Emtricitavina

Not yet recruiting
4
60
Europe
Biktarvy, Stribild, EMEA/H/C/004449, Pastille, Tablet, Biktarvy, Atripla, Stribild, EVIPLERA, REZOLSTA, TRUVADA
Consorci Mar Parc de Salut de Barcelona, Consorci Mar Parc de Salut de Barcelona
Bone health (bone mineral density, microarchitecture and bone quality) in HIV individuals under antiretroviral treatment with tenofovir disoproxil fumarate (TDF) that change treatment to bictegravir-tenofovir alafenamide-emtricitavin (BIC) Salud ósea (densidad mineral ósea, microarquitectura y calidad ósea) en personas con VIH bajo tratamiento antirretroviral con tenofovir disoproxil fumarato (TDF) que cambia el tratamiento a bictegravir-tenofovir alafenamida-emtricitavina (BIC), bone health in persons with HIV treatment based on TDF that change the treatment to bictegravir-TAF salud ósea en personas con VIH y tratamiento antirretroviral con TDF que cambian el tratamiento a bictegravir-TAF, Diseases [C] - Virus Diseases [C02]
 
 
2019-001961-34: ANRS 173 ALTAR (ALlégement du Traitement AntiRétroviral) ANRS 173 ALTAR (ALlégement du Traitement AntiRétroviral)

Not yet recruiting
3
360
Europe
Film-coated tablet, , VIREAD or Tenofovir disoproxil fumarate (generic drug), STRIBILD 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (equivalent to 300 mg of tenofovir disoproxil fumarate or 136 mg of tenofovir), BIKTARVY bictegravir sodium equivalent to 50 mg of bictegravir, 200 mg of emtricitabine, and tenofovir alafenamide fumarate equivalent to 25 mg of tenofovir alafenamide., ISENTRESS, TIVICAY, DESCOVY 200 mg of emtricitabine and tenofovir alafenamide fumarate equivalent to 10 mg of tenofovir alafenamide, GENVOYA 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine and tenofovir alafenamide fumarate equivalent to 10 mg of tenofovir alafenamide, EPIVIR or Lamivudine (generic drugs), TRUVADA or Emtricitabine and tenofovir disoproxil fumarate (Generic drug)
INSERM ANRS, ANRS
Hiv Infection Infection par le VIH, Hiv Infection Infection par le VIH, Diseases [C] - Virus Diseases [C02]
 
 
ALTAR, NCT04051970: Reducing Antiretroviral Treatments

Active, not recruiting
3
360
Europe
Antiretroviral
ANRS, Emerging Infectious Diseases, Institut National de la Santé Et de la Recherche Médicale, France
HIV-1-infection
09/23
03/24
2014-001348-39: Clinical trial to determinate viral load in seminal fluid in HIV-positive patients without previous treatment Ensayo clinico para medir la carga viral en el semen de pacientes VIH que no han recibido tratamiento antirretroviral previamente

Ongoing
2
36
Europe
EVIPLERA, STRIBILD, TRUVADA, PREZISTA, NORVIR, EVIPLERA, STRIBILD, TRUVADA, PREZISTA, NORVIR
Fundación pública andaluza para la gestión de la investigación en salud de Sevilla (FISEVI), Infectious disease department
HIV-1 infection Infección por VIH-1
 
 
NCT03205696: Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

Active, not recruiting
N/A
72
US
Antiretrovirals, Genvoya, Stribild
University of California, Los Angeles, Los Angeles LGBT Center, Tulane University
Human Immunodeficiency Virus
07/21
11/22
NCT05064020: Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
N/A
162
US
Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY], Biktarvy, BIC/FTC/TAF
State University of New York at Buffalo, Gilead Sciences
HIV-1-infection
12/24
12/24

Download Options